In the meantime, in order to maximize the rates of detection of ovarian cancer even in cases in which serum levels of CA125 could not give a diagnostic clue, HE4 has been proposed; therefore, it is estimated that two thirds of patients diagnosed with early or advanced stage of the disease will exhibit increased levels of HE4. Here, WFDC2 is linked to ovarian cancer.